FRESENIUS MEDICAL CARE AG shares fell nearly 6% Tuesday morning after reporting a 0.4% decline in United States treatment volumes. This marks the second consecutive quarter of shrinking U.S. volumes for the Germany-based dialysis provider. Investors are weighing persistent volume weakness against the company's ongoing profitability overhaul and 2026 outlook confirmation.

U.S. Volume Declines Pressure Revenue